[EN] PROSTAGLANDIN E2 RECEPTOR 4 ANTAGONISTS AND USES THEREOF<br/>[FR] ANTAGONISTES DU RÉCEPTEUR 4 DE LA PROSTAGLANDINE E2 ET LEURS UTILISATIONS
申请人:TEON THERAPEUTICS INC
公开号:WO2020251957A1
公开(公告)日:2020-12-17
Disclosed herein are compounds, compositions, and methods for modulating the prostaglandin E2 receptor 4 (EP4) with the compounds and compositions disclosed herein. Also described are methods of treating diseases or disorders that are mediated by the action of prostaglandin E2 (PGE2) at the prostaglandin E2 receptor 4 (EP4), such as cancer, with EP4 antagonists.
本文披露了一种用于调节前列腺素E2受体4(EP4)的化合物、组合物和方法,其中所披露的化合物和组合物。还描述了一种使用EP4拮抗剂治疗由前列腺素E2(PGE2)在前列腺素E2受体4(EP4)介导的疾病或紊乱的方法,如癌症。